Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1733 to 1782 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADCK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aarf domain containing kinase 1. [source:refseq;acc:nm\_020421]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.567\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01303\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NOLA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleolar protein family a, member 2; component of the h/aca snornp. [source:refseq;acc:nm\_017838]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.921\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.081\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01296\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LARS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
leucyl-trna synthetase. [source:refseq;acc:nm\_020117]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.189\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GTF2F1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription initiation factor iif, alpha subunit (tfiif-alpha) (transcription initiation factor rap74). [source:swissprot;acc:p35269]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.921\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.081\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LARS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
probable leucyl-trna synthetase, mitochondrial precursor (ec 6.1.1.4) (leucine--trna ligase) (leurs). [source:swissprot;acc:q15031]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.189\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIPT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lipoate-protein ligase, mitochondrial precursor (ec 6.-.-.-) (lipoate biosynthesis protein) (lipoyl ligase) (lipoyltransferase). [source:swissprot;acc:q9y234]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
206.595\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.258\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01289\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUBG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tubulin gamma-1 chain (gamma-1 tubulin) (gamma-tubulin complex component 1) (gcp-1). [source:swissprot;acc:p23258]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DAD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
defender against cell death 1 (dad-1). [source:swissprot;acc:p46966]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TCP11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
t-complex 11. [source:refseq;acc:nm\_018679]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUBG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tubulin gamma-2 chain (gamma-2 tubulin). [source:swissprot;acc:q9nrh3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1743\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-mrna cleavage factor i, 59 kda subunit. [source:refseq;acc:nm\_024811]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.176\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.402\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01288\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1744\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SGPL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sphingosine-1-phosphate lyase 1; sphingosine-1-phosphate lyase. [source:refseq;acc:nm\_003901]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.423\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
222.215\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01272\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1745\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4-aminobutyrate aminotransferase, mitochondrial precursor (ec 2.6.1.19) (gamma-amino-n-butyrate transaminase) (gaba transaminase) (gaba aminotransferase) (gaba-at) (gaba-t). [source:swissprot;acc:p80404]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OAT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ornithine aminotransferase, mitochondrial precursor (ec 2.6.1.13) (ornithine--oxo-acid aminotransferase). [source:swissprot;acc:p04181]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ERCC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tfiih basal transcription factor complex helicase subunit (ec 3.6.1.-) (dna-repair protein complementing xp-d cells) (xeroderma pigmentosum group d complementing protein) (cxpd) (dna excision repair protein ercc-2). [source:swissprot;acc:p18074]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.452\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.845\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0127\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1748\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bloom's syndrome protein (ec 3.6.1.-) (recq protein-like 3) (dna helicase, recq-like, type 2). [source:swissprot;acc:p54132]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.673\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.971\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01269\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1749\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MLH3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna mismatch repair protein mlh3 (mutl protein homolog 3). [source:swissprot;acc:q9uhc1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.058\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.485\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01264\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1750\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIMCH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
similar to lim domain only 7 (fragment). [source:sptrembl;acc:q8n6m2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.57\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AP1M2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 2 subunit (mu-adaptin 2) (adaptor protein complex ap-1 mu-2 subunit) (golgi adaptor ha1/ap1 adaptin mu-2 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 2) (ap-mu chain family member mu1b). [source:swissprot;acc:q9y6q5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01259\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BARD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
brca1-associated ring domain protein 1 (bard-1). [source:swissprot;acc:q99728]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.991\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01258\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MSRA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peptide methionine sulfoxide reductase (ec 1.8.4.6) (protein- methionine-s-oxide reductase) (peptide met(o) reductase). [source:swissprot;acc:q9uj68]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.091\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.362\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01256\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSAT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTPS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ctp synthase (ec 6.3.4.2) (utp--ammonia ligase) (ctp synthetase). [source:swissprot;acc:p17812]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.609\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
178.393\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01242\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1756\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEGF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
megf6 (fragment). [source:sptrembl;acc:o75095]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.811\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.09\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTPS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytidine triphosphate synthase ii; ctp synthetase type 2; utp-ammonia ligase; ctp synthetase isoform; cytidine 5'-triphosphate synthetase 2. [source:refseq;acc:nm\_019857]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.537\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
178.325\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0124\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PCYT2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ethanolamine-phosphate cytidylyltransferase (ec 2.7.7.14) (phosphorylethanolamine transferase) (ctp:phosphoethanolamine cytidylyltransferase). [source:swissprot;acc:q99447]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
233.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
230.595\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01238\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RUVBL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ruvb-like 1 (ec 3.6.1.-) (49-kda tata box-binding protein-interacting protein) (49 kda tbp-interacting protein) (tip49a) (pontin 52) (nuclear matrix protein 238) (nmp 238) (54 kda erythrocyte cytosolic protein) (ecp-54) (tip60-associated protein 54-alpha) (tap54-alpha). [source:swissprot;acc:q9y265]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.086\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin light chain 1, skeletal muscle isoform (mlc1f) (a1 catalytic) (alkali). [source:swissprot;acc:p05976]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
233.45\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
230.595\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin light chain 1, slow-twitch muscle b/ventricular isoform (mlc1sb) (alkali). [source:swissprot;acc:p08590]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDUFS6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 13 kda-a subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-13kd-a) (ci-13kd-a). [source:swissprot;acc:o75380]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1763\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYL6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin light chain 1, slow-twitch muscle a isoform (mlc1sa) (alkali). [source:swissprot;acc:p14649]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1764\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin light chain 1, embryonic muscle/atrial isoform (pro1957). [source:swissprot;acc:p12829]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1765\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
isoleucyl-trna synthetase, cytoplasmic (ec 6.1.1.5) (isoleucine--trna ligase) (ilers) (irs). [source:swissprot;acc:p41252]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.698\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.369\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1766\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTHFD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
c-1-tetrahydrofolate synthase, cytoplasmic (c1-thf synthase) [includes: methylenetetrahydrofolate dehydrogenase (ec 1.5.1.5); methenyltetrahydrofolate cyclohydrolase (ec 3.5.4.9); formyltetrahydrofolate synthetase (ec 6.3.4.3)]. [source:swissprot;acc:p11586]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.932\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.732\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01223\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1767\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l24 (l30). [source:swissprot;acc:p38663]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
198.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01221\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1768\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HSD17B4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
estradiol 17 beta-dehydrogenase 4 (ec 1.1.1.62) (17-beta-hsd 4) (17-beta-hydroxysteroid dehydrogenase 4). [source:swissprot;acc:p51659]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
185.276\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
187.534\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01219\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1769\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTAP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5'-methylthioadenosine phosphorylase (ec 2.4.2.28) (mta phosphorylase) (mtapase). [source:swissprot;acc:q13126]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.016\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.734\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1770\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AP1M1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 1 subunit (mu-adaptin 1) (adaptor protein complex ap-1 mu-1 subunit) (golgi adaptor ha1/ap1 adaptin mu-1 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 1) (clathrin coat assembly protein ap47) (clathrin coat associated protein ap47) (ap-mu chain family member mu1a). [source:swissprot;acc:q9bxs5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.082\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.778\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1771\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FTSJ1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative ribosomal rna methyltransferase 1 (ec 2.1.1.-) (rrna (uridine-2'-o-)-methyltransferase) (jm23 protein). [source:swissprot;acc:q9uet6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.016\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.734\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1772\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPTBN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
spectrin beta chain, brain 2 (spectrin, non-erythroid beta chain 2) (beta-iii spectrin). [source:swissprot;acc:o15020]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.032\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
225.739\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01214\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1773\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPTBN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
spectrin beta chain, brain 1 (spectrin, non-erythroid beta chain 1) (beta-ii spectrin) (fodrin beta chain). [source:swissprot;acc:q01082]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1774\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PGM3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphoacetylglucosamine mutase (ec 5.4.2.3) (pagm) (acetylglucosamine phosphomutase) (n-acetylglucosamine-phosphate mutase) (phosphoglucomutase 3). [source:swissprot;acc:o95394]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1775\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPTLC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine palmitoyltransferase 1 (ec 2.3.1.50) (long chain base biosynthesis protein 1) (lcb 1) (serine-palmitoyl-coa transferase 1) (spt 1) (spt1). [source:swissprot;acc:o15269]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.757\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.274\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01212\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1776\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUPL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleoporin like 1. [source:refseq;acc:nm\_014089]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.878\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.286\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0121\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGEF4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 4 isoform a; apc-stimulated guanine nucleotide exchange factor. [source:refseq;acc:nm\_015320]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGEF9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cdc42 guanine exchange factor 9; hpem-2 collybistin. [source:refseq;acc:nm\_015185]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PBX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-b-cell leukemia transcription factor-1 (homeobox protein pbx1) (homeobox protein prl). [source:swissprot;acc:p40424]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.874\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01206\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
germ cell-less. [source:refseq;acc:nm\_022471]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.335\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.877\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PBX3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-b-cell leukemia transcription factor-3 (homeobox protein pbx3). [source:swissprot;acc:p40426]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
206.332\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
203.874\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C1orf179\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hyporthetical protein mgc27169. [source:refseq;acc:nm\_176782]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/